South Korea-based Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and...
India-based Cipla has announced an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals for the comme...
Australia-based Telix Pharmaceuticals has announced that the Brazilian Health Regulatory Agency (Agencia Nacional d...
ABL Diagnostics, a Euronext-listed leader in molecular diagnostics, has announced an exclusive distribution agreement wi...
Proteomics International Laboratories, a pioneer in precision diagnostics, has announced the launch of its first...
American medtech firm GE HealthCare has announced the launch of the AltiX AI.i edition of Mac-Lab, CardioLab and ComboLa...
Gene Bio Medical (GBM), a leading Canadian biotechnology company specialising in molecular diagnostics, has signed a&nbs...
British pharmaceutical firm AstraZeneca has entered into a definitive agreement to acquire Belgium-based biotech startup...
Teva Hong Kong has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network (KLN)....
Shimadzu Corporation, a global leader in the precision instrumentation industry, and Diagnostics Development Hub (DxD Hu...
Italy-based Tethis S.p.A., a pioneer in standardised liquid biopsy platform development, and Sheba Medical Center, ...
US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its De...
South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnos...
The offering includes: €850 million floating rate notes, due March 2027, bearing interest at 3-month Eur...
Japan-headquartered Astellas Pharma Inc. and Yaskawa Electric Corporation have signed a definitive agreement t...
SK Chemicals, which developed Korea's first herbal medicine product for osteoarthritis, Joins, has expanded its pai...
China's oncology firm Antengene Corporation has announced that the Indonesia National Agency of Drug and Food Control (B...
Taiwan-based Health2Sync, a leading digital health company specialising in chronic disease management, has raised over $...
